Quantcast

Latest Garo H. Armen Stories

2008-11-05 09:00:34

Antigenics Inc. (NASDAQ: AGEN) reported results for the quarter ended September 30, 2008.

2008-11-03 09:00:39

Antigenics Inc. (NASDAQ: AGEN) today announced that Garo Armen, Ph.D., the company's chairman and chief executive officer, will present at the Rodman and Renshaw 10th Annual Healthcare Conference at the Palace Hotel in New York on Monday, November 10, 2008 at 12:25 p.m. Eastern Time. Dr.

2008-10-23 12:00:26

Antigenics, a biotechnology company, has submitted a marketing authorization application to the European Medicines Agency requesting approval for Oncophage in earlier-stage, localized renal cell carcinoma under the conditional authorization provision.

2008-10-22 06:00:08

Antigenics Inc. (NASDAQ: AGEN) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA) requesting approval for Oncophage(R) in earlier-stage, localized renal cell carcinoma (kidney cancer) under the conditional authorization provision.

2008-09-30 09:01:00

Antigenics, a biotechnology company, has announced that the FDA has granted the necessary permission to allow for the export of Oncophage to Russia.

2008-09-15 09:00:58

Antigenics Inc. (NASDAQ: AGEN) today announced that Garo Armen, Ph.D., the company's chairman and chief executive officer, will present at the UBS 2008 Global Life Sciences Conference at the Grand Hyatt New York on Monday, September 22, 2008 at 8:00 a.m. Eastern Time. Dr.

2008-07-31 09:01:26

Antigenics Inc. (NASDAQ: AGEN) reported results today for the quarter ended June 30, 2008.

2005-10-10 11:15:12

NEW YORK (Reuters) - Antigenics Inc. said on Monday a preliminary analysis showed its Oncophage skin cancer vaccine failed to meet the primary goal of a trial, but appeared to prolong survival in a group of patients, lifting shares 18 percent.

2005-10-10 08:37:12

NEW YORK (Reuters) - Antigenics Inc. said on Monday a preliminary analysis showed certain advanced skin cancer patients taking its Oncophage vaccine survived more than 50 percent longer in a late-stage test, sending shares up 30 percent in pre-market trading.


Word of the Day
edulcoration
  • The act of sweetening by admixture of some saccharine substance.
The word 'edulcoration' comes from a Latin word meaning 'making sweet'.